FDA inspection
Shandong Qilu King-phar Pharmaceutical Co., Ltd.: FDA inspection ending Mar 24, 2017
FDA inspection 1009139 · No Action Indicated (NAI) · Jinan
Key facts
| Inspection ID | 1009139 |
|---|---|
| Firm | Shandong Qilu King-phar Pharmaceutical Co., Ltd. |
| FEI number | 3003657816 |
| Address | No. 21 Qinglonglu, Pingyinxian |
| City | Jinan |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | Mar 24, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data